The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing contracts, assesses the latest opportunities and threats for manufacturers, and identifies recent mergers, acquisitions, and financing among CMOs. It also updates readers on facility-level news, such as planned site openings and closures, Good Manufacturing Practice (GMP) inspections, and investments in technology and equipment.
Report Scope
This report gives an important monthly update on the pharmaceutical outsourcing industry, based on analysis from the analyst's experts and our databases covering deals, companies, drugs, financials, news, clinical trials, and more. This report is required reading for:- CMO executives and strategic decision-makers: to improve understanding of the CMO industry and provide a critical input for strategic planning efforts.
- Sourcing and procurement executives in bio/pharmaceutical companies: to improve understanding of crucial components of the supply base that will provide insights for supplier selection and management.
- Investors, advisors, and consultants: they can gain a deeper understanding of the CMO market and important insights for identifying potential investment targets.
Reasons to Buy
- Understand current trends and equip yourself with forward-thinking strategies to navigate challenges and capitalise on emerging trends driving the pharmaceutical manufacturing industry. Use our radar to identify developments and innovations with high impact.
- Discover the latest opportunities and threats in the contract manufacturing industry, based on clinical trials and regulatory decisions.
- Learn about the past quarter’s M&A and financing deals in the manufacturing space.
- Identify the latest contract service agreements.
- Develop your competitor or market intelligence by reading about inspection outcomes and facility investments.
- Stay ahead of disruption with updates on supply chain obstacles and new regulations.
Table of Contents
- Industry Trends
- UK-US AbbVie $100B deal aligns drug pricing strategy with domestic manufacturing goals
- FDA announced new flexibilities for cell and gene therapy manufacturing
- Industry Analysis
- Contract service agreements
- Contract manufacturing - opportunities and threats
- Quarterly mergers, acquisitions, and financing - Q1 2026
- Value Chain
- API chemical
- API biologics - cell, gene, vaccine, and virus
- API biologics (protein and peptide)
- Commercial dose manufacturing and packaging
- Clinical dose manufacturing
- Analytical services
- About the Analyst
- About the Authors
- Contact the Publisher
Table 1: Contract service agreements
Table 2: Contract manufacturing: opportunities and threats - potentially positive
Table 3: Contract manufacturing: opportunities and threats - potentially negative
Table 4: Mergers, acquisitions, and financing - Q1 2026
List of Figures
Figure 1: Contract service agreements by deal geography, by volume
Figure 2: Deals by deal geography, by volume - mergers, acquisitions, and financing
Figure 3: The contract manufacturing value chain
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 1315 Capital LLC
- 3P Biopharmaceuticals SLU
- 3SBio Inc
- Agenus Inc
- Agios Pharmaceuticals Inc
- Agno Pharmaceuticals LLC
- Alcami Corporation
- Almac Group Ltd
- Amgen
- AOP Health
- Ascidian Therapeutics Inc
- Axolabs GmbH
- Bachem Holding AG
- Bayer AG
- BeOne Medicines AG
- Beta Drugs Ltd
- Bio Elpida
- BioNet-Asia Co Ltd
- Biogen Inc
- Bionova Scientific Inc
- Bionovis SA
- Boehringer Ingelheim
- Bora Pharmaceuticals Co Ltd
- Boost Pharma ApS
- Brenus Pharma SAS
- Bristol Myers Squibb
- BSP Pharmaceuticals SpA
- Carbogen Amcis AG
- Catalent Inc
- Cellares Corp
- Cellistic
- Charles River Laboratories International Inc
- ChemCon GmbH
- Chemika Pty Ltd
- Chester Medical Solutions Ltd
- Chime Biologics Ltd
- City of Hope
- Coating Place Inc
- Codexis Inc
- Corden Pharma International GmbH
- Corden Pharma Switzerland LLC
- Cytora Ltd
- Darnytsia
- Dongyao Pharmaceutical Co Ltd
- Earth Vision Bio Solutions Inc
- EMD Serono Inc
- Enveda Biosciences Inc
- Esteve Pharmaceuticals SA
- Evotec SE
- Flamma SpA
- Forge Biologics Inc
- Fresenius Kabi USA LLC
- Frontage Laboratories Inc
- FUJIFILM Biotechnologies USA Inc
- FUJIFILM Toyama Chemical Co Ltd
- Genentech (Roche)
- Genetix Biotherapeutics Inc
- Genprex Inc
- Gilead Sciences
- GlobalData
- GSK
- Gyre Therapeutics Inc
- Hindustan Laboratories
- Hope Medicine Inc
- Hutchmed China Ltd
- Idorsia Pharmaceutical Ltd
- Ingenza Ltd
- Ionis Pharmaceuticals Inc
- Janssen Biotech Inc
- Jazz Pharmaceuticals Inc
- Jubilant Generics Ltd
- Jubilant Pharmaceuticals Incorporation
- Juzen Chemical Corp
- Just Evotec Biologics Inc
- LG CNS Co Ltd
- Lindus Health Ltd
- Lonza Biologics Inc
- Made Scientific Inc
- MedPharm Ltd
- Merck
- MIAS Pharma Ltd
- Minaris Advanced Therapies LLC
- MorphoSys US Inc
- Novartis
- Nutriband
- Nivian Lifesciences Private Limited
- Orchard Therapeutics Ltd
- PathoQuest SAS
- Patheon France SAS
- Patheon Italia SpA
- Patheon NV
- PCI Pharma Services
- Phlow Corp
- PharmaKorell GmbH
- Piramal Pharma Solutions Inc
- Pocono Pharmaceutical Inc
- ProBioGen AG
- Quotient Sciences Ltd
- Recipharm AB
- Richter-Helm Biologics GmbH & Co KG
- Rentschler Biopharma SE
- Roslin Cell Therapies Ltd
- Rottendorf Pharma GmbH
- RS Italia Sarl
- Samsung Biologics America Inc
- Sanofi
- Seran BioScience LLC
- Sharp Packaging Services LLC
- Sharp Sterile Manufacturing LLC
- Shield TX (UK) Ltd
- Shionogi & Co Ltd
- Shize Biotech
- SpringWorks Therapeutics Inc
- Swedish Orphan Biovitrum AB
- Symbiotec Pharmalab Pvt Ltd
- Symbiosis Pharmaceutical Services Ltd
- Syenex Inc
- Takeda Pharmaceutical Co Ltd
- TerSera Therapeutics LLC
- Tjoapack BV
- Tower Laboratories Ltd
- VarmX BV
- Vetter Pharma-Fertigung GmbH & Co KG
- Vicebio Ltd
- Winder Laboratories LLC
- WuXi Biologics Co Ltd
- WuXi STA (Shanghai) Co Ltd
- WuXi XDC Cayman Inc
- Zag Bio Inc
- Zydus Lifesciences
- Zylidac Bio LLC
